DSM appoints new Chief Technology Officer
Heerlen, NL, Royal DSM, the global Life Sciences and Materials Sciences company, today announces the following:
Marcel Wubbolts, currently Vice President R&D DSM Innovation Center, will assume the position of Chief Technology Officer for DSM as of October 1, reporting to Rob van Leen, Chief Innovation Officer.
Marcel holds a PhD from the University of Groningen, NL, was post-doc and Assistent Professor at the ETH in Zürich. He joined DSM as a senior scientist and became Managing Director of DSM Biotech GmbH, in Jülich, Germany. Thereafter, he was Competence Manager Biocatalysis & Biotransformations and then became Program Director at the DSM Innovation Center in Delft, the Netherlands, running the Industrial (White) Biotechnology program. Since January 2011 he is at his current position.
Marcel has published over 80 publications and patents in the area of biocatalysis and metabolic engineering. He serves on the board of the WG Applied Biocatalysis of the Dutch Society for Biotechnology (NBV); the board of the European Federation of Biotechnology Section on Applied Biocatalysis (ESAB); the Industrial Biotechnology council of EuropaBio; the supervisory board of ERA-NET Industrial Biotechnology and leads the Industrial Biotechnology Section of Suschem, European Technology Platform for Sustainable Chemistry.
Marcel will succeed Jos Put who will continue to be an advisor to DSM e.g. in the field of material sciences and for several of the DSM Science and Technology awards.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.